varenicline has been researched along with 2019 Novel Coronavirus Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 7 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, J; Cox, S; Jackson, SE; Shahab, L | 1 |
| Bauld, L; Beard, E; Brown, J; Kock, L; Shahab, L; Tattan-Birch, H; West, R | 1 |
| Baliunas, D; Comans, T; Gartner, C; Hollingworth, SA; Pole, JD; Sullivan, C | 1 |
| Baugh, M; Benbow, E; Clegg, H; Coyne, J; Crossfield, A; Evison, M; Groom, K; Hewitt, K; Howle, F; Hryhorskyj, L; Huddart, H; Manley, E; Mawson, A; Moore, R; Murray, RL; Pearce, C; Rutherford, M; Shackley, D | 1 |
| Bertrand, D; Bertrand, S; Carlson, EC; Macsai, M; Nau, J | 1 |
| Davis, JM; Masclans, L; Rose, JE | 1 |
| Ashare, R; Duerr, C; Hawk, LW; Mahoney, MC; Schlienz, N | 1 |
2 trial(s) available for varenicline and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
E-cigarettes to Augment Stop Smoking In-person Support and Treatment With Varenicline (E-ASSIST): A Pragmatic Randomized Controlled Trial.
Topics: Adult; Bupropion; COVID-19; Electronic Nicotine Delivery Systems; Humans; Nicotinic Agonists; Smoking; Varenicline | 2023 |
Adaptive Smoking Cessation Using Precessation Varenicline or Nicotine Patch: A Randomized Clinical Trial.
Topics: Bupropion; COVID-19; Female; Humans; Male; Middle Aged; Nicotine; Pandemics; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2023 |
5 other study(ies) available for varenicline and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Prevalence of use and real-world effectiveness of smoking cessation aids during the COVID-19 pandemic: a representative study of smokers in England.
Topics: Adult; Bayes Theorem; COVID-19; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; England; Humans; Pandemics; Prevalence; Smokers; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2022 |
Publicly subsidised smoking cessation medicines in times of COVID-19 in Australia: An interrupted time series analysis.
Topics: Bupropion; COVID-19; Humans; Interrupted Time Series Analysis; Nicotine; Nicotinic Agonists; Pandemics; Pharmaceutical Preparations; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2023 |
Patient survey examining the experience of care of a hospital-based opt-out tobacco dependency treatment service (the CURE Project).
Topics: Adult; Aftercare; COVID-19; Hospitals; Humans; Nicotiana; Patient Discharge; Smoking Cessation; State Medicine; Tobacco Use Cessation Devices; Varenicline | 2022 |
The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline.
Topics: alpha7 Nicotinic Acetylcholine Receptor; COVID-19; Humans; Nicotinic Agonists; Receptors, Nicotinic; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Varenicline | 2023 |
Making lemonade from SARS coronavirus-2 lemons: Transitioning a smoking cessation trial to a virtual platform.
Topics: Adult; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; Counseling; COVID-19; Female; Humans; Internet; Male; Pandemics; Pneumonia, Viral; SARS-CoV-2; Smoking Cessation; Smoking Cessation Agents; Substance-Related Disorders; Telephone; Treatment Outcome; Varenicline | 2020 |